相似文献
1
Oral lesions postinjection of the first administration of Pfizer-BioNTech SARS-CoV-2 (BNT162b2) vaccine.首次接种辉瑞-生物科技公司的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）（BNT162b2）疫苗后出现的口腔病变
Oral Dis. 2022 Nov;28 Suppl 2:2605-2607. doi: 10.1111/odi.13912. Epub 2021 May 24.
2
Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine.辉瑞-BioNTech公司的BNT162b2疫苗接种后出现的慢性苔藓样糠疹：一种新型的SARS-CoV-2疫苗接种后的皮肤反应。
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e979-e981. doi: 10.1111/jdv.18418. Epub 2022 Jul 20.
3
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine.辉瑞-生物科技（BNT162b2） COVID-19 疫苗加强针接种后对 SARS-CoV-2 奥密克戎变异株的中和能力增强。
Viruses. 2022 Sep 13;14(9):2023. doi: 10.3390/v14092023.
4
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
5
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
6
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.辉瑞-生物技术公司（Pfizer-BioNTech）疫苗 BNT162b2 对预防 12-17 岁青少年感染 SARS-CoV-2 的疫苗有效性的临时估计-亚利桑那州，2021 年 7 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1761-1765. doi: 10.15585/mmwr.mm705152a2.
7
Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination.辉瑞-生物科技（BNT162b2）SARS-CoV-2 疫苗接种后对血液学参数和血小板减少症的评估。
Saudi Med J. 2022 Jun;43(6):567-571. doi: 10.15537/smj.2022.43.6.20220135.
8
The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine.年龄、性别和合并症对两剂国药疫苗接种后 SARS-CoV-2 刺突抗体诱导的影响，以及辉瑞/生物科技加强疫苗的影响。
Front Immunol. 2022 May 30;13:817597. doi: 10.3389/fimmu.2022.817597. eCollection 2022.
9
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.BNT162b2（辉瑞-生物科技）和 ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗对降低感染 SARS-CoV-2 的 Delta 变体（B.1.617.2）的敏感性的有效性。
BMC Infect Dis. 2022 Mar 20;22(1):270. doi: 10.1186/s12879-022-07239-z.
10
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.美国 2022 年 6 月关于在 6 个月至 5 岁儿童中使用 Moderna 和辉瑞-BioNTech COVID-19 疫苗的免疫实践咨询委员会临时建议。
MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):859-868. doi: 10.15585/mmwr.mm7126e2.
引用本文的文献
1
Pathophysiology of oral lesions subsequent to SARS-CoV-2 vaccination: A systematic review.新型冠状病毒2型疫苗接种后口腔病变的病理生理学：一项系统评价。
J Oral Maxillofac Pathol. 2024 Jul-Sep;28(3):443-454. doi: 10.4103/jomfp.jomfp_511_23. Epub 2024 Oct 15.
2
A comprehensive review of oral microenvironment changes and orofacial adverse reactions after COVID-19 vaccination: The good, the bad, and the ugly.新冠疫苗接种后口腔微环境变化及口面部不良反应的综合综述：好的、坏的与难看的。
Health Sci Rep. 2024 Mar 13;7(3):e1967. doi: 10.1002/hsr2.1967. eCollection 2024 Mar.
3
Oral lesions after COVID-19 vaccination: Immune mechanisms and clinical approach.新型冠状病毒肺炎疫苗接种后的口腔病变：免疫机制与临床处理
Infect Med (Beijing). 2022 Sep;1(3):171-179. doi: 10.1016/j.imj.2022.06.004. Epub 2022 Jun 19.
4
Neurological complications following mRNA COVID-19 vaccination: Oral and lower limb paresthesia. A case discussion and literature review.新型冠状病毒肺炎mRNA疫苗接种后的神经系统并发症：口腔及下肢感觉异常。病例讨论及文献综述
J Clin Exp Dent. 2023 Oct 1;15(10):e866-e869. doi: 10.4317/jced.60891. eCollection 2023 Oct.
5
Systematic review of the oral manifestations produced by the SARS-CoV-2 vaccine.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗所致口腔表现的系统评价
J Clin Exp Dent. 2023 Jul 1;15(7):e578-e583. doi: 10.4317/jced.60688. eCollection 2023 Jul.
6
Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review.抗 SARS-CoV-2 疫苗接种后的口腔病变：系统评价。
Int J Environ Res Public Health. 2022 Aug 17;19(16):10228. doi: 10.3390/ijerph191610228.
7
Unusual Case of Painful Glossitis and Xerostomia Following Vaccination with Pfizer-BioNTech SARS-CoV-2 (BNT162b2).辉瑞-生物科技 SARS-CoV-2（BNT162b2）疫苗接种后出现舌痛和口干的不寻常病例。
Am J Case Rep. 2022 Aug 20;23:e937212. doi: 10.12659/AJCR.937212.
8
Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases.在 mRNA COVID-19 疫苗接种运动背景下诊断出的血液系统恶性肿瘤：两例报告。
Medicina (Kaunas). 2022 Jun 30;58(7):874. doi: 10.3390/medicina58070874.
9
Various painful oral adverse reactions following COVID-19 vaccination: a case series.接种 COVID-19 疫苗后出现的各种口腔疼痛不良反应：病例系列研究。
BMC Oral Health. 2022 Mar 8;22(1):64. doi: 10.1186/s12903-022-02100-w.
10
Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18-30 Years Old): An Independent Post-Marketing Study.18至30岁年轻成年人中基于mRNA的COVID-19疫苗的副作用：一项独立的上市后研究。
Pharmaceuticals (Basel). 2021 Oct 15;14(10):1049. doi: 10.3390/ph14101049.
Zotero 插件